Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

POLYENDOCRINE METABOLIC OVARIAN SYNDROME (PMOS): NEW NAME FOR PCOS TO IMPROVE DIAGNOSIS AND CARE OF CONDITION AFFECTING 3.1 MILLION IN THE UK

Contributed by: ResponseSource

Issued via ResponseSource Press Release Wire, on behalf of Verity - Pcos Charity.

Tags

Pmos
Pcos

More Like This

Flo Health Supports PMOS Awareness Month by Offering a Free Symptom Checker For the Condition During the Entire Month of September

SheMed Launches At-Home PMOS Screening Kit, Connecting Women to Answers and Care

PR Newswire associated0

Ulike Brings Science, Innovation and Support Together at London Forum on PMOS

Business Wire logo

Nexpring Health Invests in May Health to Advance a Novel Technology to Treat PCOS-Related Infertility

New Study Published in Menopause Validates Flo Health's Perimenopause Symptom Scale, Co-Developed With Mayo Clinic Clinicians

She Had No Clue, Until She Did: Clue's new campaign spotlights seven women who found the missing piece behind years of symptoms, questions and hormonal uncertainty

PR Newswire associated0

MAY HEALTH APPOINTS SEASONED MEDTECH EXECUTIVE, COLBY HOLTSHOUSE, AS PRESIDENT AND CEO

MetPsy, a global network for metabolic psychiatry, launches with $20M Baszucki Group grant for new McLean Hospital clinical care and research center.

Global Network for the Advancement of Metabolic Psychiatry (MetPsy) Launches with $20 Million Investment in Clinical Care, Education and Research at McLean Hospital

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us